These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 8278896)

  • 1. Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide.
    Votaw JR; Kessler RM; de Paulis T
    Synapse; 1993 Nov; 15(3):177-90. PubMed ID: 8278896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
    Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
    Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer.
    Mukherjee J; Yang ZY; Das MK; Brown T
    Nucl Med Biol; 1995 Apr; 22(3):283-96. PubMed ID: 7627142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors.
    Mukherjee J; Yang ZY; Brown T; Roemer J; Cooper M
    Life Sci; 1996; 59(8):669-78. PubMed ID: 8761017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
    Neve KA; Henningsen RA; Kinzie JM; De Paulis T; Schmidt DE; Kessler RM; Janowsky A
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1108-16. PubMed ID: 2138666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol.
    Christian BT; Narayanan T; Shi B; Morris ED; Mantil J; Mukherjee J
    J Cereb Blood Flow Metab; 2004 Mar; 24(3):309-22. PubMed ID: 15091112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters.
    Frost JJ; Wagner HN
    Brain Res; 1984 Jul; 305(1):1-11. PubMed ID: 6331593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of D2 dopamine receptor-specific carbon-11-YM-09151-2 binding in the canine brain by PET: importance of partial volume correction.
    Hatazawa J; Hatano K; Ishiwata K; Itoh M; Ido T; Kawashima K; Meguro K; Watanuki S; Seo S
    J Nucl Med; 1991 Apr; 32(4):713-8. PubMed ID: 1672888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides.
    Kessler RM; Ansari MS; de Paulis T; Schmidt DE; Clanton JA; Smith HE; Manning RG; Gillespie D; Ebert MH
    J Nucl Med; 1991 Aug; 32(8):1593-600. PubMed ID: 1831229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quantitative analysis of D2-dopamine receptors in baboon striatum in vivo with 3-N-[2'-18F]fluoroethylspiperone using positron emission tomography.
    Jovkar S; Wienhard K; Pawlik G; Coenen HH
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):720-6. PubMed ID: 2384543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.
    Vermeulen RJ; Drukarch B; Verhoeff NP; Goosen C; Sahadat MC; Wolters EC; van Royen EA; Stoof JC
    Synapse; 1994 Jun; 17(2):115-24. PubMed ID: 7916490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and equilibrium analyses of [(123)I]epidepride binding to striatal and extrastriatal dopamine D(2) receptors.
    Fujita M; Seibyl JP; Verhoeff NP; Ichise M; Baldwin RM; Zoghbi SS; Burger C; Staley JK; Rajeevan N; Charney DS; Innis RB
    Synapse; 1999 Dec; 34(4):290-304. PubMed ID: 10529723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
    Vessotskie JM; Kung MP; Chumpradit S; Romaniello G; McElgin W; Frederick D; Malison RT; Kung HF
    J Nucl Med; 1995 Jul; 36(7):1282-8. PubMed ID: 7790957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.
    Votaw JR; Ansari MS; Mason NS; Schmidt D; de Paulis T; Holburn G; Clanton JA; Votaw DB; Manning RG; Kessler RM
    J Nucl Med; 1995 Jul; 36(7):1316-21. PubMed ID: 7790962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
    Kung HF; Pan S; Kung MP; Billings J; Kasliwal R; Reilley J; Alavi A
    J Nucl Med; 1989 Jan; 30(1):88-92. PubMed ID: 2783457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.